Company Filing History:
Years Active: 2004-2012
Title: Anette Margareta Johansson: Innovator in Neuropharmacology
Introduction
Anette Margareta Johansson is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of neuropharmacology, particularly through her innovative work on serotonin and norepinephrine reuptake inhibitors. With a total of 6 patents to her name, Johansson's research has the potential to impact the treatment of various neurological disorders.
Latest Patents
Among her latest patents is a serotonin and norepinephrine reuptake inhibitor, which details its formula, uses, and methods for preparation. Another notable invention is related to 4-amino-piperidine derivatives as monoamine uptake inhibitors. This invention provides compounds that inhibit the uptake of one or more monoamines, including serotonin, norepinephrine, and dopamine, which may be useful in treating disorders of the central and peripheral nervous systems.
Career Highlights
Throughout her career, Anette has worked with esteemed organizations such as Eli Lilly and Company and Independent Pharmaceutical Ab. Her work in these companies has allowed her to develop and refine her innovative ideas, contributing to advancements in pharmacological treatments.
Collaborations
Anette has collaborated with notable professionals in her field, including Serge Louis Boulet and Peter Thaddeus Gallagher. These collaborations have further enriched her research and development efforts.
Conclusion
Anette Margareta Johansson's contributions to neuropharmacology through her patents and collaborations highlight her as a key figure in the field. Her work continues to pave the way for advancements in the treatment of neurological disorders.